Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05563038 · ClinicalTrials.gov registry record · NA

Scrambler Therapy for Post-Stroke Pain

A NA study of Post-Stroke Pain, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05563038: Recruiting NA study of Post-Stroke Pain, sponsored by Johns Hopkins University.

NCT05563038 is a NA study of Post-Stroke Pain that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 100 participants, above the 18-participant average among 4 other Post-Stroke Pain trials with a reported enrollment target (456% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05563038, a NA study of Post-Stroke Pain, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.

Primary Outcome

At least a 50% reduction in post stroke pain

Conditions Studied

Interventions

  • DEVICE Scrambler Therapy for Post Stroke Pain

Study Locations (1)

Maryland

  • Johns Hopkins Bayview Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-05-15
Est. Completion 2027-12
Phase NA
Johns Hopkins University

1,448 total trials

What NCT05563038 shows while recruiting

NCT05563038 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 18-participant average among 4 other Post-Stroke Pain trials with a reported enrollment target (456% higher).

The record links to 1 condition, with Post-Stroke Pain appearing as the primary indexed condition, and to 1 intervention - of which Scrambler Therapy for Post Stroke Pain is the first listed.

NCT05563038 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05563038 about?

NCT05563038 is a clinical study titled "Scrambler Therapy for Post-Stroke Pain". The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.

What is the current status of trial NCT05563038?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-05-15. Estimated completion is 2027-12.

What conditions does trial NCT05563038 study?

This clinical trial studies the following conditions: Post-Stroke Pain.

What interventions are being tested in trial NCT05563038?

The interventions under investigation include: Scrambler Therapy for Post Stroke Pain (DEVICE).

Who is sponsoring clinical trial NCT05563038?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05563038 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Stroke Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05563038, the US trial registry maintained by the National Library of Medicine. NCT05563038 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.